LimFlow, Now Part of Stryker

LimFlow, Now Part of Stryker is a leading provider of medical technology based in Irvine, California, specializing in innovative solutions for patients with Chronic Limb-Threatening Ischemia (CLTI).

We offer a groundbreaking percutaneous procedure, the LimFlow System, designed to restore blood flow to ischemic feet and prevent amputation – a critical need for patients facing limited treatment options. Our technology addresses the challenges of end-stage CLTI, providing a minimally invasive alternative to traditional methods and significantly improving patient outcomes.

LimFlow’s approach focuses on revolutionizing healthcare by offering a new, effective treatment for ‘no option’ CLTI patients, ultimately helping them regain mobility and improve their quality of life. We are dedicated to advancing vascular medicine and reducing the devastating impact of limb loss.

Founded in 2012, LimFlow has rapidly grown to become a trusted name in the field, now integrated into Stryker, further solidifying our commitment to delivering life-changing medical advancements. We are committed to providing hope and a better future for patients worldwide.